<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32532</article-id><article-id pub-id-type="doi">10.7554/eLife.32532</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-100425"><name><surname>Lee</surname><given-names>Chang Hoon</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8953-9069</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-98721"><name><surname>Zhang</surname><given-names>Hongwei H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100426"><name><surname>Singh</surname><given-names>Satya P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100427"><name><surname>Koo</surname><given-names>Lily</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100428"><name><surname>Kabat</surname><given-names>Juraj</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100429"><name><surname>Tsang</surname><given-names>Hsinyi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100430"><name><surname>Singh</surname><given-names>Tej Pratap</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-98722"><name><surname>Farber</surname><given-names>Joshua M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3224-0378</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Laboratory of Molecular Immunology</institution>, <institution>National Institute of Allergy and Infectious Diseases</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Research Technologies Branch</institution>, <institution>National Institute of Allergy and Infectious Diseases</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-8269"><name><surname>Yokoyama</surname><given-names>Wayne M</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Washington University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jfarber@niaid.nih.gov</email> (JF);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>02</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e32532</elocation-id><history><date date-type="received"><day>06</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>02</month><year>2018</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-32532-v1.pdf"/><abstract><p>Many mediators and regulators of extravasation by bona fide human memory-phenotype T cells remain undefined. Mucosal-associated invariant T (MAIT) cells are innate-like, anti-bacterial cells that we found excelled at crossing inflamed endothelium. They displayed abundant selectin ligands, with high expression of <italic>FUT7</italic> and <italic>ST3GAL4</italic>, and expressed CCR6, CCR5, and CCR2, which played non-redundant roles in trafficking on activated endothelial cells. MAIT cells selectively expressed CCAAT/enhancer-binding protein delta (C/EBPδ). Knockdown of C/EBPδ diminished expression of <italic>FUT7</italic>, <italic>ST3GAL4</italic> and <italic>CCR6,</italic> decreasing MAIT cell rolling and arrest, and consequently the cells' ability to cross an endothelial monolayer <italic>in vitro</italic> and extravasate in mice. Nonetheless, knockdown of C/EBPδ did not affect <italic>CCR2</italic>, which was important for the step of transendothelial migration. Thus, MAIT cells demonstrate a program for extravasastion that includes, in part, C/EBPδ and C/EBPδ-regulated genes, and that could be used to enhance, or targeted to inhibit T cell recruitment into inflamed tissue.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>Intramural Research Program</award-id><principal-award-recipient><name><surname>Farber</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. NIAID approved submission per standard Institute procedures.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Mice were housed under specific pathogen free conditions at the National Institutes of Health in an American Association for the Accreditation of Laboratory Animal Care-approved facility. Animals were studied under protocol LMI-13 as approved by the Animal Care and Use Committee, NIAID, NIH.</p></fn><fn fn-type="other"><p>Human subjects: Human blood cells were obtained by the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, under  protocol 99-CC-0168 approved by the Institutional Review Board. Informed consent was obtained after explanation of the risks.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-32532-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>